PubMed · 2026-06-27
A review finds that despite 20 years of gut microbiome research in humans, very little of it has translated into real clinical treatments or public health tools, and the field needs better scientific frameworks, standardization, and training to close that gap.
Human gut microbiome research remains largely confined to early translational phases (T0-T1), with very few findings reaching clinical or public health practice after two decades of study.
Key barriers include high individual variability in gut microbiomes, lack of standardized methods across studies, and insufficient causal evidence — making it hard to know what interventions actually work.
The review proposes integrating core translational medical research principles — including bidirectional knowledge flow, patient-centered design, and interdisciplinary collaboration — as the primary path forward.